Navigation Links
Omaxe Infrastructure & Construction Private Ltd Receives LoI for Construction of Allopathic Medical College and Associated Hospital at Saharanpur, UP With Construction Value of Approx 250 Crores
Date:8/21/2008

NEW DELHI, August 21 /PRNewswire/ -- Omaxe Infrastructure & Construction Private Ltd(OICPL), a wholly owned subsidiary of Omaxe Ltd has received a Letter of Intent for the construction of Allopathic Medical College and Associated Hospital at Saharanpur, UP from UP Government through UP RNNL. The construction value of the project is Rs250 crores approx.

The project is spread over an area of 62 acres with total built up area of 15.66 lac sq ft. It will comprise of an Allopathic Medical College and a 500-bedded hospital.

OICPL will also construct an Academic building, an auditorium, academic hospital building. Apart from this, there will be hostels for students, a separate hostel for nurses and resident doctors, guest house, autopsy building, pump house, and principal residence.

According to Mr. Rohtas Goel, CMD, Omaxe Ltd., "Omaxe Infrastructure & Construction Private Ltd is an outcome of Omaxe Ltd's strategic plan to diversify its business into new markets. The announcement is consistent with our company vision of providing state-of-art infrastructure and creating opportunities to help meet local and global infrastructure demands. Omaxe Infrastructure & Construction Private Ltd is slated to bid for other larger infrastructure projects".

The construction of the project will be completed in two years.

The financial standing of Omaxe Ltd and rising demand of the projects will further add to its value. Omaxe Ltd has prepaid 60% (Rs 180 crore) of the total term facility (Rs 300 crore) taken by the company from Indiabulls Financial Services Limited. Inspite of this term facility being for a period of 3 years , all dues being serviced in time and a substantially higher collateral security lying with the lender, it has been felt by the company to prepay the loan in order to free up the equity. Omaxe is planning to retire the outstanding of Rs 120 crore in near future. This step of Omaxe Ltd shall further strengthen the trust of investors in the company.

For more details, please contact:

Dhananjay Srivastava

DGM - PR & Media

Omaxe House

Mobile:+91(0)9818099270

Anurag Nigam / Neeti Mathur

Adfactors PR Pvt Ltd

Mobile: +91(0)9818296645 / +91(0)9871551232


'/>"/>
SOURCE Omaxe Ltd
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Osteotechs Plexur(R) Technology to Be Used in Craniofacial Reconstruction Program Funded by the Armed Forces Institute of Regenerative Medicine
2. Cellular construction methods emulated
3. Enerkem announces progress on construction of Canadas first cellulosic ethanol plant
4. DNA is blueprint, contractor and construction worker for new structures
5. White Paper Details Infection Control Challenges Hospitals Must Address During Construction
6. China-Biotics, Inc. Receives Approval to Begin Construction on Large-Scale Manufacturing Facility
7. TEI Biosciences Launches SurgiMend(TM) Collagen Matrix for Soft Tissue Reconstruction
8. Total Site Solutions Selected to Provide Construction Management Services for Existing Pharmaceutical and Biotech Customer for Data Center Expansion Project
9. MicroTech Ranks No. 285 on Inc. Magazines 2008 List of the 500 Fastest Growing Private Companies in America
10. Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US
11. ThromboGenics Announces Private Investors Acquire 8% Stake in the Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... , Jan. 18, 2017  HUYA Bioscience International, (HUYA), ... China,s pharmaceutical innovations, announced today a ... Innovation and Investment Company (referred to as CAS Innovation). ... innovations discovered by leading scientists at CAS to meet ... HUYA is the first company to have recognized ...
(Date:1/17/2017)... West Point, IA (PRWEB) , ... January 17, ... ... approval from China for Balance™ GT soybeans. The new Balance™ GT Soybean Performance ... tolerance to glyphosate and isoxaflutole, the active ingredient in the new Balance® Bean ...
(Date:1/17/2017)... Mass. , Jan. 17, 2017   Pulmatrix, ... stage biopharmaceutical company developing innovative inhaled therapies to address ... for treating fungal infections in the lungs of CF ... Disease Product" (QIDP) by the U.S. Food & Drug ... which is designed to speed the development of novel ...
(Date:1/17/2017)... UK (PRWEB) , ... January ... ... presented by surgeons at the 2016 annual meeting of the North American ... clinical outcomes, for patients in the majority of cases, when PEEK-OPTIMA™ HA ...
Breaking Biology Technology:
(Date:1/6/2017)... , Jan. 6, 2017  Privately-held CalciMedica, Inc., ... in healthy volunteers of a novel calcium release-activated ... acute pancreatitis. Acute pancreatitis, sudden ... mild disorder, but can be very serious.  In severe ... sepsis, where extended hospital stays, time in the ...
(Date:1/4/2017)... 2017  For the thousands of attendees at this year,s International Consumer ... health and biometric measurement devices and services, will be featuring its new ... in A&D Medical,s special CES Exhibit Suite , the new upper ... the company,s WellnessConnected product platform.  ... ...
(Date:12/22/2016)... MOUNTAIN VIEW, Calif. , Dec. 20, 2016  As ... all levels, 23andMe, the leading personal genetics company, recently released ... Only Me . The book focuses on the topics ... the Next Generation Science Standards (NGSS) taught in elementary school ... the second in a series by illustrator Ariana Killoran ...
Breaking Biology News(10 mins):